+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Respiratory Disease Testing Market By Product and Service (Instruments & Devices, Assays & Reagents, Services & Software), By Test Type (Mechanical Tests, Imaging Tests, Others), By Disease, By Purpose, By End User, By Region, Forecast & Opportunities, 2025

  • PDF Icon

    Report

  • May 2020
  • Region: Global
  • TechSci Research
  • ID: 5031352
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Respiratory Disease Testing Market is expected to grow at a CAGR during the forecast period. The Global Respiratory Disease Testing Market is driven by the rising population having respiratory disorders. Moreover, governments across the globe are investing more on healthcare infrastructure, which is anticipated to positively impact the growth of the market during the forecast period. Also, increase in research and developmental activities is further expected to bolster the growth of the market over the next few years.

The Global Respiratory Disease Testing Market is segmented based on product and service, test type, disease, purpose, end-user, company, and region. Based on product and service, the market can be categorized into instruments & devices, assays & reagents, services & software. Out of which, the instruments & devices segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to the constant need of diagnostic instruments and devices in laboratories, point-of-care, and home care. Also, the services and software segment are forecast to register high growth over the coming years on account of rapid technological innovations. In terms of test type, the market is fragmented into mechanical tests, OSA diagnostic tests, other test types, imaging tests, traditional diagnostic tests and molecular diagnostic tests. Among them, the traditional diagnostic tests segment is anticipated to dominate the market during the next five years which can be primarily attributed to the quick turnaround time of these tests.

Major players operating in the Global Respiratory Disease Testing Market include Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Biomérieux, Alere Inc., Bio-Rad Laboratories, Inc., Cosmed, Seegene Inc, Sdi Diagnostics, Bosch Healthcare Solutions, ADI Instruments, Qiagen, Siemens Healthcare, Co-Diagnostics, Inc., and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and estimate the market size of the Global Respiratory Disease Testing Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global Respiratory Disease Testing Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global Respiratory Disease Testing Market based on product and service, test type, disease, purpose, end-user, company and regional distribution.
  • To identify dominant region or segment in the Global Respiratory Disease Testing Market.
  • To identify drivers and challenges for the Global Respiratory Disease Testing Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Respiratory Disease Testing Market.
  • To conduct pricing analysis for the Global Respiratory Disease Testing Market.
  • To identify and analyze the profile of leading players operating in the Global Respiratory Disease Testing Market.
  • To identify key sustainable strategies adopted by market players in the Global Respiratory Disease Testing Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals/clinics across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The author analyzed the hospitals/clinics and presence of all major players across the globe.

The author calculated the market size of the Global Respiratory Disease Testing Market by using a bottom-up approach, wherein the data for various end-user segments was recorded and forecast for the future years. The author sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Respiratory disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to respiratory disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Respiratory Disease Testing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Respiratory Disease Testing Market, By Product and Service:
  • Instruments & Devices
  • Assays & Reagents
  • Services & Software

Global Respiratory Disease Testing Market, By Test Type:
  • Mechanical Tests
  • OSA Diagnostic Tests
  • Other Test Types
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests

Global Respiratory Disease Testing Market, By Disease:
  • Tuberculosis
  • Asthma
  • Lung Cancer
  • Chronic Obstructive Pulmonary Disease
  • Other Respiratory Diseases

Global Respiratory Disease Testing Market, By Purpose:
  • Minute Ventilation
  • Peak Inspiratory flow (PIF)
  • Inspiratory Vital Capacity (IVC)
  • Peak Expiratory Flow (PEF)
  • Forced Vital Capacity (FVC)
  • Forced Expiratory Volume (FEV1)
  • Others

Global Respiratory Disease Testing Market, By End-User:
  • Hospital/Clinical Laboratories
  • Reference Laboratories
  • Physician Offices
  • Others

Global Respiratory Disease Testing Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Respiratory Disease Testing Market.

Available Customizations:
With the given market data, the author offers customizations according to a client’s specific needs.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Respiratory Disease Testing Market4. Executive Summary5. Voice of Customer
6. Global Respiratory Disease Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product and Service (Instruments & Devices, Assays & Reagents, Services & Software)
6.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Tests, Other Test Types, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests)
6.2.3. By Disease (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Other Respiratory Diseases)
6.2.4. By Purpose (Minute Ventilation, Peak Inspiratory flow (PIF), Inspiratory Vital Capacity (IVC), Peak Expiratory Flow (PEF), Forced Vital Capacity (FVC), Forced Expiratory Volume (FEV1), Others)
6.2.5. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Other End Users)
6.2.6. By Company (2019)
6.2.7. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Respiratory Disease Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product and Service
7.2.2. By Test Type
7.2.3. By Disease
7.2.4. By Purpose
7.2.5. By End User
7.2.6. By Country
7.2.7. Competition Outlook
7.3. Asia-Pacific: Country Analysis
7.3.1. China Respiratory Disease Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product and Service
7.3.1.2.2. By Test Type
7.3.1.2.3. By Disease
7.3.1.2.4. By End User
7.3.2. India Respiratory Disease Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product and Service
7.3.2.2.2. By Test Type
7.3.2.2.3. By Disease
7.3.2.2.4. By End User
7.3.3. Australia Respiratory Disease Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product and Service
7.3.3.2.2. By Test Type
7.3.3.2.3. By Disease
7.3.3.2.4. By End User
7.3.4. Japan Respiratory Disease Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product and Service
7.3.4.2.2. By Test Type
7.3.4.2.3. By Disease
7.3.4.2.4. By End User
7.3.5. South Korea Respiratory Disease Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product and Service
7.3.5.2.2. By Test Type
7.3.5.2.3. By Disease
7.3.5.2.4. By End User
8. Europe Respiratory Disease Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product and Service
8.2.2. By Test Type
8.2.3. By Disease
8.2.4. By Purpose
8.2.5. By End User
8.2.6. By Country
8.2.7. Competition Outlook
8.3. Europe: Country Analysis
8.3.1. France Respiratory Disease Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product and Service
8.3.1.2.2. By Test Type
8.3.1.2.3. By Disease
8.3.1.2.4. By End User
8.3.2. Germany Respiratory Disease Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product and Service
8.3.2.2.2. By Test Type
8.3.2.2.3. By Disease
8.3.2.2.4. By End User
8.3.3. United Kingdom Respiratory Disease Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product and Service
8.3.3.2.2. By Test Type
8.3.3.2.3. By Disease
8.3.3.2.4. By End Use
8.3.4. Italy Respiratory Disease Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product and Service
8.3.4.2.2. By Test Type
8.3.4.2.3. By Disease
8.3.4.2.4. By End User
8.3.5. Spain Respiratory Disease Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product and Service
8.3.5.2.2. By Test Type
8.3.5.2.3. By Disease
8.3.5.2.4. By End User
9. North America Respiratory Disease Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product and Service
9.2.2. By Test Type
9.2.3. By Disease
9.2.4. By Purpose
9.2.5. By End User
9.2.6. By Country
9.2.7. Competition Outlook
9.3. North America: Country Analysis
9.3.1. United States Respiratory Disease Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product and Service
9.3.1.2.2. By Test Type
9.3.1.2.3. By Disease
9.3.1.2.4. By End User
9.3.2. Mexico Respiratory Disease Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product and Service
9.3.2.2.2. By Test Type
9.3.2.2.3. By Disease
9.3.2.2.4. By End User
9.3.3. Canada Respiratory Disease Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product and Service
9.3.3.2.2. By Test Type
9.3.3.2.3. By Disease
9.3.3.2.4. By End User
10. South America Respiratory Disease Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product and Service
10.2.2. By Test Type
10.2.3. By Disease
10.2.4. By Purpose
10.2.5. By End User
10.2.6. By Country
10.2.7. Competition Outlook
10.3. South America: Country Analysis
10.3.1. Brazil Respiratory Disease Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product and Service
10.3.1.2.2. By Test Type
10.3.1.2.3. By Disease
10.3.1.2.4. By End User
10.3.2. Argentina Respiratory Disease Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product and Service
10.3.2.2.2. By Test Type
10.3.2.2.3. By Disease
10.3.2.2.4. By End User
10.3.3. Colombia Respiratory Disease Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product and Service
10.3.3.2.2. By Test Type
10.3.3.2.3. By Disease
10.3.3.2.4. By End Use
11. Middle East and Africa Respiratory Disease Testing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product and Service
11.2.2. By Test Type
11.2.3. By Disease
11.2.4. By Purpose
11.2.5. By End User
11.2.6. By Country
11.2.7. Competition Outlook
11.3. MEA: Country Analysis
11.3.1. South Africa Respiratory Disease Testing Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product and Service
11.3.1.2.2. By Test Type
11.3.1.2.3. By Disease
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Respiratory Disease Testing Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product and Service
11.3.2.2.2. By Test Type
11.3.2.2.3. By Disease
11.3.2.2.4. By End User
11.3.3. UAE Respiratory Disease Testing Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product and Service
11.3.3.2.2. By Test Type
11.3.3.2.3. By Disease
11.3.3.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments14. Patent Analysis
15. Competitive Landscape
15.1. Philips Healthcare
15.2. Becton, Dickinson & Company
15.3. Abbott Laboratories
15.4. Thermo Fisher Scientific Inc.
15.5. Biomérieux
15.6. Alere Inc.
15.7. Bio-Rad Laboratories, Inc.
15.8. Cosmed
15.9. Seegene Inc.
15.10. Sdi Diagnostics
15.11. Bosch Healthcare Solutions
15.12. ADI Instruments
15.13. Qiagen
15.14. Siemens Healthcare
15.15. Co-Diagnostics, Inc.
16. Strategic Recommendations17. About the author & Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Philips Healthcare
  • Becton, Dickinson & Company
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Biomérieux
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Cosmed
  • Seegene Inc.
  • Sdi Diagnostics
  • Bosch Healthcare Solutions
  • ADI Instruments
  • Qiagen
  • Siemens Healthcare
  • Co-Diagnostics, Inc.